Nobu Desensitizer lube
Natural health product licensed in Canada
- Licence holder
- Kaytel Media Group Inc.
- NPN or DIN-HM
- 80084033
- Status
- Inactive licence
- Licence date
- 27 March 2018
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Phénoxyéthanol, Hydroxyde de sodium, Poly(éthylène glycol), Ethylhexylglycérine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Gel | 1 Tous les jours |
Uses authorised in Canada
For reducing oversensitivity in advance of intercourse. For temporary male genital desensitisation, helping to slow the onset of ejaculation. Helps in temporarily retarding the onset of ejaculation/temporarily slowing the onset of ejaculation/temporarily prolonging the time until ejaculation. Helps in the prevention of premature ejaculation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a health care practitioner.
- Contre-indications
If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80084033
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.